newsfilter
← Latest News
GlobeNewswire·

Achilles Therapeutics to Present at Upcoming Conferences

LONDON, May 03, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the Company will be taking part in the follow